Smith Group Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-30
| Closed | -$1K | – | 402 |
|
|
2021
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 362 |
|
|
2021
Q1 | $1K | Sell |
30
-1,000
| -97% | -$33.3K | ﹤0.01% | 327 |
|
|
2020
Q4 | $25K | Hold |
1,030
| – | – | ﹤0.01% | 242 |
|
|
2020
Q3 | $43K | Hold |
1,030
| – | – | ﹤0.01% | 216 |
|
|
2020
Q2 | $49K | Sell |
1,030
-20
| -2% | -$951 | ﹤0.01% | 204 |
|
|
2020
Q1 | $66K | Hold |
1,050
| – | – | ﹤0.01% | 234 |
|
|
2019
Q4 | $130K | Hold |
1,050
| – | – | 0.01% | 229 |
|
|
2019
Q3 | $70K | Buy |
1,050
+420
| +67% | +$28K | ﹤0.01% | 257 |
|
|
2019
Q2 | $50K | Hold |
630
| – | – | ﹤0.01% | 275 |
|
|
2019
Q1 | $70K | Sell |
630
-2,200
| -78% | -$244K | ﹤0.01% | 281 |
|
|
2018
Q4 | $285K | Sell |
2,830
-100
| -3% | -$10.1K | 0.01% | 217 |
|
|
2018
Q3 | $370K | Buy |
+2,930
| New | +$370K | 0.01% | 209 |
|
|
2014
Q1 | – | Sell |
-24,455
| Closed | -$1.67M | – | 433 |
|
|
2013
Q4 | $1.67M | Sell |
24,455
-125
| -0.5% | -$8.54K | 0.06% | 165 |
|
|
2013
Q3 | $1.7M | Buy |
+24,580
| New | +$1.7M | 0.07% | 159 |
|